IL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population

Journal of Thoracic Oncology

Volumn 5, Issue 3, 2010, Pages 299-304

  Kiyohara, Chikako ^a   Horiuchi, Takahiko ^a   Takayama, Koichi ^a   Nakanishi, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Alcohol; IL1B; Interaction; Polymorphism; Smoking

Indexed keywords

ALCOHOL; INTERLEUKIN 1BETA;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; JAPANESE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 77649327816     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181c8cae3     Document Type: Article

References (45)

1. Aggarwal BB, Shishodia S, Sandur SK, et al. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006;72:1605-1621.
2. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg 2006;391:499-510.
3. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-867.
4. Kang S, Kim JW, Park NH, et al. Interleukin-1 beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci 2007;22:110-113.
5. Emmendoerffer A, Hecht M, Boeker T, et al. Role of inflammation in chemical-induced lung cancer. Toxicol Lett 2000;112-113:185-191.
6. Smith CJ, Perfetti TA, King JA. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 2006;18: 667-677.
7. Bird S, Zou J, Wang T, et al. Evolution of interleukin-1beta. Cytokine Growth Factor Rev 2002;13:483-502.
8. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-2147.
9. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002;20:S1-S13.
10. Engels EA, Wu X, Gu J, et al. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res 2007;67:6520-6527. (Pubitemid 47037538)
11. Zienolddiny S, Ryberg D, Maggini V, et al. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 2004;109:353-356.
12. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
13. Haukim N, Bidwell JL, Smith AJ, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 2002;3: 313-330.
14. Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 2004;50:1976-1983.
15. Wobbe CR, Struhl K. Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro. Mol Cell Biol 1990;10:3859-3867.
16. Kominato Y, Galson D, Waterman WR, et al. Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU. 1. Mol Cell Biol 1995;15:58-68.
17. Chen H, Wilkins LM, Aziz N, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006;15:519-529.
18. Thi Tran HT, Takeshima Y, Surono A, et al. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splicedonor site both in vivo and in vitro. Mol Genet Metab 2005;85:213-219.
19. Bellone E, Balestra P, Ribizzi G, et al. An abnormal mRNA produced by a novel PMP22 splice site mutation associated with HNPP. J Neurol Neurosurg Psychiatry 2006;77:538-540.
20. Pociot F, Molvig J, Wogensen L, et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
21. Hernandez-Guerrero C, Monzon-Bordonaba F, Jimenez-Zamudio L, et al. In-vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-alpha and interleukin-1beta. Mol Hum Reprod 2003;9:625-629.
22. Campa D, Hung RJ, Mates D, et al. Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:538-539. (Pubitemid 40270124)
23. Lee KM, Shen M, Chapman RS, et al. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 2007;28:1437-1441.
24. Ter-Minassian M, Zhai R, Asomaning K, et al. Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis 2008;29:2147-2152.
25. Shimoyama T, Everett SM, Fukuda S, et al. Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection. J Clin Pathol 2001;54:332-334.
26. Szabo G. Consequences of alcohol consumption on host defence. Alcohol Alcohol 1999;34:830-841.
27. Percy C, van Holten V, Muir C. (Eds.) International Classification of Diseases for Oncology (ICD-O), 2nd Ed. Geneva, Switzerland: World Health Organization; 1990.
28. Kiyohara C, Yoshimasu K, Shirakawa T, et al. Genetic polymorphisms and environmental risk of lung cancer: a review. Rev Environ Health 2004;19:15-38.
29. Accessed at http://www.kenkounippon21.gr.jp/kenkounippon21/about/ kakuron/index.html. Accessed August 26, 2009.
30. Holman CD, English DR, Milne E, et al. Meta-analysis of alcohol and all-cause mortality: a validation of NHMRC recommendations. Med J Aust 1996;164:141-145.
31. Benedetti A, Parent ME, et al. Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal. Cancer Detect Prev 2009;32:352-362.
32. Rothman K. (Eds.) Measuring Interaction. New York: Oxford University Press; 2002.
33. Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol 2005;20:575-579.
34. Kalilani L, Atashili J. Measuring additive interaction using odds ratios. Epidemiol Perspect Innov 2006;3:5.
35. Accessed at http://www.ncbi.nlm.nih.gov/SNP/snp-ref.cgi?rs-1143634. Accessed August 26, 2009.
36. Takamatsu M, Yamauchi M, Maezawa Y, et al. Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 2000;95:1305-1311.
37. Niimi T, Sato S, Tomita H, et al. Lack of association with interleukin 1 receptor antagonist and interleukin-1beta gene polymorphisms in sarcoidosis patients. Respir Med 2000;94:1038-1042.
38. Freudenheim JL, Ritz J, Smith-Warner SA, et al. Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr 2005;82:657-667.
39. Bandera EV, Freudenheim JL, Vena JE. Alcohol consumption and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2001;10:813-821.
40. Potter JD, McMichael AJ. Alcohol, beer and lung cancer-a meaningful relationship? Int J Epidemiol 1984;13:240-242.
41. International Agency for Research on Cancer. (Eds.) Alcohol Drinking. Lyon: IARC; 1988.
42. Accessed at http://www.nta.go.jp/kohyo/tokei/kokuzeicho/h18/h18.pdf. Accessed August 26, 2009.
43. Riboli E, Cornee J, Macquart-Moulin G, et al. Cancer and polyps of the colorectum and lifetime consumption of beer and other alcoholic beverages. Am J Epidemiol 1991;134:157-166.
44. Mandrekar P, Catalano D, White B, et al. Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10. Alcohol Clin Exp Res 2006;30:135-139.
45. Druesne-Pecollo N, Tehard B, Mallet Y, et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 2009;10:173-180.